Literature DB >> 28314116

Secretory Proteome Analysis of Streptomycin-Resistant Mycobacterium tuberculosis Clinical Isolates.

Divakar Sharma1, Deepa Bisht1.   

Abstract

Tuberculosis still remains one of the most fatal infectious diseases. Streptomycin (SM) is the drug of choice, especially for patients with multidrug-resistant tuberculosis or category II patients, because it targets the protein synthesis machinery by interacting with steps of translation. Several mechanisms have been proposed to explain the resistance, but our knowledge is inadequate. Secretome often plays an important role in pathogenesis and is considered an attractive reservoir for the development of novel diagnostic markers and targets. In this study, we analyze the secretory proteins of streptomycin-resistant Mycobacterium tuberculosis isolates by 2-dimensional gel electrophoresis-matrix assisted laser desorption/ionization-time-of-flight mass spectrometry and bioinformatic tools. Fifteen overexpressed proteins were identified in a resistant isolate that belonged to various categories such as virulence/detoxification/adaptation, intermediary metabolism and respiration, and conserved hypotheticals. Among them, Rv1860, Rv1980c, Rv2140c, Rv1636, and Rv1926c were proteins of an undefined role. Molecular docking of these proteins with SM showed that it binds to their conserved domains and suggests that these might neutralize/compensate the effect of the drug. The interactome also suggests that overexpressed proteins along with their interactive partner might be involved in M. tuberculosis virulence and resistance. The cumulative effect of these overexpressed proteins could involve SM resistance, and these might be used as diagnostic markers or potential drug targets.

Entities:  

Keywords:  2DE; MALDI-TOF/MS; Mycobacterium tuberculosis; bioinformatic tools; secretory proteome; streptomycin

Mesh:

Substances:

Year:  2017        PMID: 28314116     DOI: 10.1177/2472555217698428

Source DB:  PubMed          Journal:  SLAS Discov        ISSN: 2472-5552            Impact factor:   3.341


  11 in total

1.  Genetic analysis of human papilloma virus 16 E6/E7 variants obtained from cervical cancer cases in Chhattisgarh, a central state of India.

Authors:  Sanjay Singh Negi; Kuldeep Sharma; Divakar Sharma; Pushpendra Singh; Pragya Agarwala; Nighat Hussain; Anudita Bhargava; Padma Das; Sarita Agarwal
Journal:  Virusdisease       Date:  2021-07-26

2.  Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis.

Authors:  Divakar Sharma; Yogesh K Dhuriya; Nirmala Deo; Deepa Bisht
Journal:  Front Microbiol       Date:  2017-12-11       Impact factor: 5.640

3.  Role of Bacterioferritin & Ferritin in M. tuberculosis Pathogenesis and Drug Resistance: A Future Perspective by Interactomic Approach.

Authors:  Divakar Sharma; Deepa Bisht
Journal:  Front Cell Infect Microbiol       Date:  2017-06-08       Impact factor: 5.293

4.  M. tuberculosis Hypothetical Proteins and Proteins of Unknown Function: Hope for Exploring Novel Resistance Mechanisms as well as Future Target of Drug Resistance.

Authors:  Divakar Sharma; Deepa Bisht
Journal:  Front Microbiol       Date:  2017-03-21       Impact factor: 5.640

Review 5.  Potential Alternative Strategy against Drug Resistant Tuberculosis: A Proteomics Prospect.

Authors:  Divakar Sharma; Deepa Bisht; Asad U Khan
Journal:  Proteomes       Date:  2018-05-28

6.  Down-Regulation of Flagellar, Fimbriae, and Pili Proteins in Carbapenem-Resistant Klebsiella pneumoniae (NDM-4) Clinical Isolates: A Novel Linkage to Drug Resistance.

Authors:  Divakar Sharma; Anjali Garg; Manish Kumar; Faraz Rashid; Asad U Khan
Journal:  Front Microbiol       Date:  2019-12-17       Impact factor: 5.640

Review 7.  Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis.

Authors:  Saad Alghamdi; Shaheed Ur Rehman; Nashwa Talaat Shesha; Hani Faidah; Muhammad Khurram; Sabi Ur Rehman
Journal:  Molecules       Date:  2020-12-02       Impact factor: 4.411

8.  Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains.

Authors:  Nadeem Ullah; Ling Hao; Jo-Lewis Banga Ndzouboukou; Shiyun Chen; Yaqi Wu; Longmeng Li; Eman Borham Mohamed; Yangbo Hu; Xionglin Fan
Journal:  Pathogens       Date:  2021-05-15

9.  Identification of Trombospondin-1 as a Novel Amelogenin Interactor by Functional Proteomics.

Authors:  Angela Capolupo; Chiara Cassiano; Agostino Casapullo; Giuseppina Andreotti; Maria V Cubellis; Andrea Riccio; Raffaele Riccio; Maria C Monti
Journal:  Front Chem       Date:  2017-10-09       Impact factor: 5.221

Review 10.  The Neglected Contribution of Streptomycin to the Tuberculosis Drug Resistance Problem.

Authors:  Deisy M G C Rocha; Miguel Viveiros; Margarida Saraiva; Nuno S Osório
Journal:  Genes (Basel)       Date:  2021-12-17       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.